☆ 4.3 Article

Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study

JCO ONCOLOGY PRACTICE (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Facilitated cascade testing (FaCT): a randomized controlled trial

Roni Nitecki et al.

Summary: This study aims to compare the efficacy of facilitated cascade testing with standard care in genetic testing of identified first-degree relatives of patients with BRCA1/2 mutations. The hypothesis is that facilitated cascade testing will drive significantly higher uptake of genetic testing.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Add to Collection

Article Oncology

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019

Allison W. Kurian et al.

Summary: Genetic testing plays a crucial role in risk reduction and treatment for breast and ovarian cancer, but there are gaps in its evolving use, particularly in the increasing rates of variants of uncertain significance (VUS) and pathogenic variants (PVs). Testing trends show a gradual increase over the years, with a widening racial or ethnic gap seen in VUS results. In conclusion, there is a need for quality improvement in genetic testing to focus on indicated patients rather than simply adding more genes to the testing panel.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes

Sukh Makhnoon et al.

Summary: The study found that the management uptake among cascade testers of hereditary breast and ovarian cancer is high, comparable to unaffected BRCA-positive women, with differences in surgical and screening uptake rates among different age groups.

CANCER (2021)

Add to Collection

Review Medicine, Research & Experimental

Barriers and Facilitators to Genetic Service Delivery Models: Scoping Review

Melissa Raspa et al.

Summary: This review provides an overview of the barriers and facilitators to genetic service delivery models in the United States, highlighting the need to expand access to genetic services through methods such as telehealth, technical assistance, and professional training.

INTERACTIVE JOURNAL OF MEDICAL RESEARCH (2021)

Add to Collection

Review Oncology

Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention

Kristen D. Whitaker et al.

JCO PRECISION ONCOLOGY (2021)

Add to Collection

Article Oncology

Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention

Natalie E. Griffin et al.

GYNECOLOGIC ONCOLOGY (2020)

Add to Collection

Article Genetics & Heredity

Assessing relatives' readiness for hereditary cancer cascade genetic testing

Erica M. Bednar et al.

GENETICS IN MEDICINE (2020)

Add to Collection

Article Oncology

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling

Melissa K. Frey et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

Kenneth Offit et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Editorial Material Oncology

Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control

Allison W. Kurian et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Review Genetics & Heredity

The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review

Nick Dragojlovic et al.

GENETICS IN MEDICINE (2020)

Add to Collection

Article Oncology

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative

Jennifer L. Caswell-Jin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Add to Collection

Editorial Material Oncology

Identification of BRCA1 and BRCA2 Mutation Carriers Through a Traceback Framework: Consent, Privacy, and Autonomy

Marc D. Schwartz

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Oncology

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach

Goli Samimi et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Obstetrics & Gynecology

ACOG Committee Opinion No. 727

OBSTETRICS AND GYNECOLOGY (2017)

Add to Collection

© Peeref 2019-2024. All rights reserved.